Supply chains don't just need to be visible — they also need to be transparent. Alexis Bateman, director of MIT Sustainable Supply Chains, explains the difference.
While there are similar regulations and overlapping requirements governing both Mexico and U.S. customs import processes, there are drastic differences that savvy shippers should be aware of.
China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.
Given that Johnson & Johnson’s lawyers made public statements this month that the company’s talc-based products were free of asbestos, the recall couldn’t come at a worse time.
U.S. aviation regulators assessing Boeing Co.’s 737 Max sometimes didn’t follow their own rules, used out-of-date procedures and lacked the resources and expertise to fully vet the design changes implicated in two fatal crashes, a review panel has concluded.
For more than 20 years, the Business Roundtable, a lobbying group consisting entirely of chief executive officers, has maintained that the primary mission of corporations is to serve the interests of their shareholders. Now the group wants the world to believe that it values other fundamentals as well.
Political turmoil in the United Kingdom over the terms of the country’s withdrawal from the European Union — Brexit — has injected great uncertainty into the plans of companies doing business there. U.S. retailers distributing throughout the EU from the U.K. are especially affected.
A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.
When it comes to products that infringe on patents, retailers that sell them are just as vulnerable to legal action as the manufacturers that make them.